Engineering Crystallinity Gradients for Tailored CaO<sub>2</sub> Nanostructures: Enabling Alkalinity-Reinforced Anticancer Activity with Minimized Ca<sup>2+</sup>/H<sub>2</sub>O<sub>2</sub> Production.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38018769.
- Also identified by DOI 10.1021/acs.nanolett.3c01963.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CaO<sub>2</sub> nanoparticles (CNPs) can produce toxic Ca<sup>2+</sup> and H<sub>2</sub>O<sub>2</sub> under acidic pH, which accounts for their intrinsic anticancer activity but at the same time raises safety concerns upon systemic exposure. Simultaneously realizing minimized Ca<sup>2+</sup>/H<sub>2</sub>O<sub>2</sub> production and enhanced anticancer activity poses a dilemma. Herein, we introduce a "crystallinity gradient-based selective etching" (CGSE) strategy, which is realized by creating a crystallinity gradient in a CNP formed by self-assembled nanocrystals. The nanocrystals distributed in the outer layer have a higher crystallinity and thus are chemically more robust than those distributed in the inner layer, which can be selectively etched. CGSE not only leads to CNPs with tailored single- and double-shell hollow structures and metal-doped compositions but more surprisingly enables significantly enhanced anticancer activity as well as tumor growth inhibition under limited Ca<sup>2+</sup>/H<sub>2</sub>O<sub>2</sub> production, which is attributed to an alkalinity-reinforced lysosome-dependent cell death pathway.
Medical subject headings
- Nanostructures
- Neoplasms
- Nanoparticles